Clinical Studies 129

Similar documents
Orthostatic instability is an important co-factor and trigger of reflex syncope

Department of Paediatrics Clinical Guideline. Syncope Guideline

AUTONOMIC FUNCTION IS A HIGH PRIORITY

Summary and conclusions

Evaluation of Dizziness and Fainting in Children and Adolescents

The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients

Syncope By Remus Popa

POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) IT S NOT THAT SIMPLE

What are you trying to achieve? Falls Prevention, Assessment and Management Strategies. Falls can be classified into four main groups:

Contempo GIMSI Cosa cambia alla luce della letteratura in tema di terapia farmacologica

Neurocardiogenic syncope

SYNCOPE. Sanjay P. Singh, MD Chairman & Professor, Department of Neurology. Syncope

DECLARATION OF CONFLICT OF INTEREST

It s Always a Stroke; Except For When It s Not..

Syncope Update Dr Matthew Lovell, Consultant in Cardiology

Hypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to

Syncope: Evaluation of the Weak and Dizzy

Blood Pressure Measurement in SPRINT

Syncope: Evaluation of the Weak and Dizzy

Hypotensive susceptibility and antihypertensive drugs Diana Solari Santa Margherita Ligure, 7 aprile 2016

Presentation of transient loss of consciousness

Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan.

UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST CARDIAC INVESTIGATIONS PAEDIATRIC & CONGENITAL SYNCOPE INVESTIGATIONS/QUESTIONNAIRE PROTOCOL

Augusto Morales, MD; Andreea I. Stoichita, MD; and Jessica D. Wharton, MD

Cardiac Pathophysiology

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

HRV in Diabetes and Other Disorders

"Non-Epileptic Paroxysmal Events (NEPE) Erick Sell, M.D Neurology Division Children s Hospital of Eastern Ontario

University of Padova, Padua, Italy, and HARVEST Study Group, Italy

Faculty Disclosure. Sanjay P. Singh, MD, FAAN. Dr. Singh has listed an affiliation with: Consultant Sun Pharma Speaker s Bureau Lundbeck, Sunovion

Managing HTN in the Elderly: How Low to Go

Findings from the 2015 HRS Expert Consensus Document on Postural Tachycardia Syndrome (POTS) and Inappropriate Sinus Tachycardia (IST)

Falls Assessment and Medication

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Vague Neurological Conditions

Dizziness: Neurological Aspect

SYNCOPE. DEFINITION Syncope is defined as sudden and transient loss of consciousness which is secondary to period of cerebral ischemia CAUSES

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

Valutazione iniziale e stratificazione del rischio

Difficult Diagnosis: An Interactive Session

Relation between the angiotensinogen (AGT) M235T gene polymorphism and blood pressure in a large, homogeneous study population

Influence of Age, Hypertension or Myocardial Infarction on Cardiovascular Responses to Changes in Body Position

Adult Pre Participation Screening and Exercise Prescription Practicum

Exercise Training for PoTS and Syncope

The earlier BP control the better cardiovascular outcome. Jin Oh Na Cardiovascular center Korea University Medical College

Alan Barber. Professor of Clinical Neurology University of Auckland

Alan Barber. Professor of Clinical Neurology University of Auckland

What could be reffered to as dizziness by the patient?

INCREASED PULSE PRESSURE AND SYSTOLIC x HEART RATE DOUBLE PRODUCT AND CARDIOVASCULAR AUTONOMIC NEUROPATHY IN TYPE 2 DIABETIC PATIENTS

Paediatric Syncope. IAEM Clinical Guideline 10. Version 1 August, Author: Laura Heffernan

Research Article Cerebral Blood Flow, Heart Rate, and Blood Pressure Patterns during the Tilt Test in Common Orthostatic Syndromes

Association of Arg16Gly Polymorphism of the Beta-2 Adrenergic receptor with Baroreflex Sensitivity and Indices of Autonomic Cardiovascular Modulation

Suspected neurological conditions: clinical questions

Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial

Syncope Guidelines: What s New?

Guidelines Pediatric Congenital Heart Disease SYNCOPE

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?

Autonomic Mediated (Neurocardiogenic) Syncope

Distinguishing Cardiac from Non- Cardiac Syncope

Fainting (Syncope) Information for patients

Vertigo. Tunde Magyar MD, PhD

Orthostatic Fluid Shifts

Acoustic neuroma s/p removal BPPV (Crystals)- 50% of people over 65 y/ o with dizziness will have this as main reason for dizziness

BACK AND NECK PAIN QUESTIONNAIRE

Responses to Changes in Posture QUESTIONS. Case PHYSIOLOGY CASES AND PROBLEMS

Hypertension Management Controversies in the Elderly Patient

Causes of Poor BP control Rates

Adult with transient loss of consciousness faints, fits and funny turns

Management of TIA. Dr Ali Ali Consultant Stroke and Geriatrics Royal Hallamshire Hospital

Summary of recommendations

Dizziness 101 E-Class TAKE HOME POINTS

Systolic Blood Pressure Intervention Trial (SPRINT)

Syncope and Seizure Questionnaire

major public health burden

SYNOPSIS. Publications No publications at the time of writing this report.

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease

Child-Youth Epilepsy Overview, epidemiology, terminology. Glen Fenton, MD Professor, Child Neurology and Epilepsy University of New Mexico

Dizziness, postural hypotension and postural blackouts: Two cases suggesting multiple system atrophy

A Comparative Study of Physical Fitness among Rural Farmers and Urban Sedentary Group of Gulbarga District

Rapid Access Clinics for Transient Loss of Consciousness

Stroke secondary prevention. Gill Cluckie Stroke Nurse Consultant St. George s Hospital

Children with Hypertension in ED

Postural changes in blood pressure and the prevalence of orthostatic hypotension among home-dwelling elderly aged 75 years or older

PFO Closure for the Management of Migraine and Stroke

NICE Action Plan 6/13 Transient loss of consciousness ('blackouts') management in adults and young people NICE CG 109 December 2013

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders

PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD 5 mg/ ml THERAPEUTIC CLASSIFICATION Alpha-adrenoreceptor Blocker

Syncope Guidelines Update. Bernard Harbieh, FHRS AUBMC-KMC Beirut-Lebanon

Epidemiologic Measure of Association

PFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See USPI.

Sponsor. Generic drug name. Trial indication(s) Protocol number. Protocol title. Phase of Drug Development. Study Start/End Dates

New Zealand Guideline for the Assessment and Management of Transient Ischaemic Attack (TIA) User Guide

Roman Romero-Ortuno *, Matthew DL O Connell, Ciaran Finucane, Christopher Soraghan, Chie Wei Fan and Rose Anne Kenny

La sincope vasovagale come difesa

University of Groningen

Syncope Guidelines What s new? October 19 th 2017 Mohamed Aljaabari MBBCh, FACC, FHRS Consultant Electrophysiologist - Mafraq Hospital

Medicine Dr. Aso Lecture 9 Syncope and Pre-syncope

Outline. Chest Pain/Heart Attack Stroke Fits + fainting Making a 999 Call

Management of Hypertension

Transcription:

Clinical Studies 129

Syncope in migraine. The population-based CAMERA study Roland D. Thijs, 1* Mark C. Kruit, 2* Mark A. van Buchem, 2 Michel D. Ferrari, 1 Lenore J. Launer, 3,4 and J. Gert van Dijk 1 * both authors contributed equally Neurology. 2006;66(7):1034-7 [1] Department of Neurology and Clinical Neurophysiology, Leiden University Medical Center, Leiden, the Netherlands [2] Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands [3] Laboratory of Epidemiology, Demography and Biometry, Intramural Research Program, National Institute on Aging, Bethesda, Maryland, USA [4] Center for Prevention and Health Services Research, National Institute of Public Health and the Environment, Bilthoven, the Netherlands Chapter 9

Chapter 9 Abstract Objective: To examine the association between migraine and syncope-related autonomic nervous system (ANS) symptoms. Methods: We conducted a population-based study among migraineurs with and without aura (n = 323) and control subjects (n = 153). A systematic questionnaire and cardiovascular measurements during rest, while standing and after venipuncture addressed the prevalence of syncope, orthostatic intolerance, orthostatic hypotension (OH) and the postural tachycardia syndrome (POTS) in migraineurs and controls. Results: The lifetime prevalence of syncope in all participants was 41%, more often in women (45% vs. 32%, p = 0.02). Compared to controls, migraineurs had a higher lifetime prevalence of syncope (46% vs. 31%, p = 0.001), frequent syncope ( 5 attacks) (13% vs. 5%, p = 0.02) and orthostatic intolerance (32% vs. 12%, p < 0.001). There was no association between ANS symptoms and the severity of migraine or migraine subtype. Cardiovascular measurements and the prevalence of POTS and OH did not differ significantly between migraineurs and controls. Conclusion: This population-based study demonstrated an elevated prevalence of syncope and orthostatic intolerance in migraineurs without clear interictal signs of autonomic nervous system dysfunction. 132

Syncope in migraine Introduction Migraine is an episodic multifactorial neurovascular disorder characterized by recurrent attacks of disabling headache, autonomic dysfunction (migraine without aura; MO) and focal neurological aura symptoms (migraine with aura; MA). 87,105 Syncope is a paroxysmal symptom consisting of a brief, self-limiting transient loss of consciousness due to global cerebral hypoperfusion. 28 The prevalence of both syncope and migraine is high in the general population. 28,146 Several reports suggest that both conditions co-occur together more frequently than chance would predict. Fainting spells occurred more often among women with "migrainous headache" (11%) compared to controls (2%; p < 0.001) in a population based study. 165 Syncope has also been reported to frequently occur during migraine attacks. 211 However, neither study used standardized and validated methods for the diagnosis of migraine 105 and syncope. 28 The autonomic nervous system (ANS) has been studied extensively in migraineurs, mostly in clinic-based samples and for cardiovascular reflex responses mostly in-between attacks. 21,89,102-104,174,197,221,274 Results were conflicting in that both sympathetic hypofunction 21,89,102-104,174,197 and hyperfunction 274, and both parasympathetic hypofunction 102,103 and hyperfunction 274 have been reported. In the only population-based study to date, migraineurs with disabling attacks were more prone to ANS dysfunction than those with nondisabling attacks. 221 This underscores the importance of a population-based approach to avoid bias in assessing the relationship between migraine and ANS dysfunction. Previous studies did not address clinical symptoms of ANS failure, including syncope, orthostatic intolerance and the postural orthostatic tachycardia syndrome (POTS). Here, we assessed the prevalence of syncope and related symptoms in migraine using a populationbased design. Methods A complete description of the Cerebral Abnormalities in Migraine, an Epidemiological Risk Analysis (CAMERA) study population and methods has been detailed elsewhere. 143 In brief, cases and controls were randomly selected from the Genetic Epidemiology of Migraine (GEM) study, a population-based survey of 6491 Dutch adults aged 20-60 years living in two representative Dutch municipalities (Maastricht and Doetinchem). 146 863 Cases of migraine were identified according to International Headache Society (IHS) criteria; 105 54 % of the cases had not been previously diagnosed by a physician. We randomly selected both MA and 133

Chapter 9 MO patients as well as a control group that frequency matched the cases by sex, municipality and 5-year age strata. Controls were selected from those who had indicated that they had no severe headaches interfering with daily activities, and who had rated any headaches they had as 0 on the pain scale. This effectively excluded people with chronic daily headache and cluster headache. We invited 631 individuals; 476 participated in the present study (80% of migraineurs, 67% of controls). Of the remainder, 114 actively declined participation, 36 could not participate for various logistic reasons and five individuals (four migraineurs, one control) were excluded, as they had not completed the syncope questionnaire. There were no significant differences between responders and non-responders or between non-responding cases and non-responding controls concerning the following items: age, sex, cardiovascular risk factors (i.e., body mass index [BMI], smoking, cholesterol, blood pressure [BP], diabetes and oral contraceptive [OC] use). There was a trend for responders having had more years of schooling than non-responders (p=0.07). The study protocol was approved by the ethics committees of the cooperating institutions. All participants gave written informed consent and participated without any financial reimbursement. The study protocol included a structured telephone interview, a clinic visit for a standard physical and neurological examination, blood draw, and a brain MRI study. The telephone interview was carried out by one of three trained interviewers, who used a computerized, structured interview, with relevant questions presented on the computer screen that had to be read aloud literally. The hospital visit took place within 10 days of the telephone interview. Sociodemographic and medical characteristics were assessed by interview and physical examination. Education was categorized into low (primary school or lower vocational education) and high. The average alcohol intake in the past year was based on responses to questions on frequency and quantity of drinks per occasion and categorized into none, moderate (1-3 drinks/day) and high ( 3 drinks/day). Self-reported weight and height were used to calculate BMI (weight [kg]/height 2 [m]). A structured telephone questionnaire investigated the prevalence of syncope and the occurrence of symptoms (syncope, near syncope or avoidance) during prolonged standing (queues, during receptions), long hot shower, after a heavy meal, after exercise or at the sight of blood or during a venipuncture. These circumstances are known syncope triggers for patients with autonomic failure, vasovagal syncope or orthostatic intolerance, with as exceptions that venipuncture only acts as a syncope trigger for patients with vasovagal syncope and a heavy meal only for patients with autonomic failure. 28,128 134

Syncope in migraine In the interview, syncope ("fainting") was explained, to all participants with the same standard text, as a brief loss of consciousness that may be provoked by the sight of blood or while standing for a long time in the heat but that can occur without a clear provocation. Loss of consciousness due to head injury or an epileptic seizure was excluded as syncope. 'Near syncope' was defined as the symptoms which usually precede a faint but can also occur separately, and consist of dizziness, light-headedness, loss of concentration, ringing in the ears or darkening of sight. The occurrence of syncope was defined twice, first as at least one attack ("syncope ever") and secondly as "frequent syncope", i.e. five syncopal attacks or more. Diabetes mellitus, history of myocardial infarction, BMI, high alcohol intake, and use of antihypertensives, were examined as potential risk factors for syncope. 47 At the clinic visit blood pressure (BP) and heart rate (HR) were measured with an electronic oscillometric BP monitor [OMRON 711, OMRON Matsusaka Co, Japan]. Two autonomic reactivity tests were performed: the orthostatic change of BP and HR and the difference after venipuncture. BP and HR measurements were made with the subject sitting, after 5 minutes supine rest, during 1, 2, 3 and 4 minutes standing, and directly after venipuncture. The average of the measurements while standing was defined as 'standing BP' or 'standing HR'. The maximal decrease while standing was calculated by subtracting the lowest BP value while standing from the resting BP. Similarly, the resting HR value was subtracted from the highest HR while standing to calculate the maximal increase while standing. The difference after venipuncture was calculated by subtracting the value after venipuncture from the resting value. Orthostatic changes of BP and HR were measured in all but 34 participants (23 migraineurs, 11 controls). Migraine cases underwent all examinations in a headache free period ( 3 days after a migraine attack). Combined end points Orthostatic hypotension was defined as a fall in BP of at least 20 mm Hg systolic or 10 mm Hg diastolic within three minutes after standing up. 242 Orthostatic intolerance was defined as the provocation of syncope or near syncope (dizziness, light-headedness, loss of concentration, ringing in the ears or darkening of sight) upon standing or the avoidance of prolonged standing. POTS was defined as orthostatic intolerance accompanied by a HR increase of > 30 beats per minute (bpm) or by a HR > 120 bpm within 5 minutes of standing. 156 135

Chapter 9 Hypertension was defined as a systolic BP of 160 mm Hg and higher or a diastolic BP of 95 mm Hg and higher or current use of anti-hypertensive drugs. For this definition, BP was the mean of three supine BP measurements obtained at 1-minute intervals. Data of controls and migraineurs were compared with the 2 test for the comparison of proportions, the two-sided Student's t-test for normally distributed continuous variables and the nonparametric Mann-Whitney U test for continuous variables without a normal distribution. Linear regression analysis was used to explore the relation of two continuous variables. Significance was set at the 5% level. Results Population Migraineurs (n=323) and controls (n=153) participated in the study. Compared to controls, fewer migraineurs had a high alcohol intake (Table 1). No other significant differences were found in baseline population characteristics between both groups. Table 1 Characteristics of study participants Migraineurs (n = 323) Controls (n = 153) Male / Female ratio 32% 38% Age (yrs) 48 (8) 48 (8) Body Mass index (BMI) 25 (4) 24 (4) Medical history (% present) - diabetes mellitus 4 (1%) 6 (4%) - myocardial infarction 1(0.3%) - Currently uses antihypertensive medication 40 (12%) 12 (8%) High alcohol use ( 3 drinks/day) 23 (7%)* 23 (15%)* Low education 171 (53%) 81 (53%) Migraine with Aura (MA) 174 (54%) - 1 migraine attack per month 156 (48%) - Values are expressed as number (%) or as mean (SD) * p < 0.01 2 test for the comparison of proportions. Low education indicates primary school or lower vocational education. 136

Syncope in migraine Syncope questionnaire The lifetime prevalence of one or more syncopal events in all participants was 41%. A female preponderance was found for syncope (45% vs. 32%, p = 0.02). None of the potential risk factors for syncope (diabetes mellitus, history of myocardial infarction, BMI, high alcohol intake, and use of antihypertensives) had a significant association with the prevalence of syncope. Compared to controls, migraineurs had a significantly higher lifetime prevalence of both syncope and frequent syncope (Table 2). Migraineurs reported symptoms (syncope/near syncope/avoidance) during prolonged standing, a long hot shower, or after exercise significantly more often than controls. Table 2 Syncope questionnaire Migraineurs (n = 323) Controls (n = 153) p value Syncope ever 46% 31% 0.001 - women 50% 32% - men 35% 26% Frequent ( 5x) syncope 13% 5% 0.02 - women 17% 6% - men 1% 5% fainters Age at first faint (years) 21 ± 13 23 ± 13 0.3 Age at last faint (years) 30 ± 14 29 ± 13 0.6 Fainted previous year 12% 9% 0.5 Total number of faints 6 ± 16 6 ± 14 0.005 Symptoms - prolonged standing 32% 12% <0.001 - long hot shower 11% 2% 0.001 - after a heavy meal 4% 3% 0.4 - after exercise 23% 5% <0.001 - at the sight of blood 9% 7% 0.6 OH 16% 14% 0.7 POTS 3% 2% 0.5 Values are expressed as proportion or as mean ± standard deviation * Significance p < 0.05 2 test (proportions) or Mann-Whitney U test (continuous variables) 137

Chapter 9 Table 3 Orthostatic test Migraineurs (n = 300) Controls (n = 142) SBP (mmhg) Supine 133.3 (20.2) 133.0 (20.0) Standing 133.8 (17.4) 134.8 (17.7) Max. decrease while standing 6.6 (10.9) 5.3 (11.2) Difference after venipuncture -0.7 (10.7) -1.6 (11.2) DBP (mmhg) Supine 85.5 (10.8) 83.8 (11.2) Standing 92.7 (10.4) 92.3 ( 9.5) Max.decrease while standing -2.8 ( 7.3) -3.7 ( 7.3) Difference after venipuncture -4.0 ( 7.4) -5.4 ( 8.9) HR (bpm) Supine 68.1 (10.6) 67.6 (11.2) Standing 78.6 (11.7) 78.8 (11.6) Max. increase while standing 14.5 ( 7.7) 14.8 ( 7.2) Difference after venipuncture -4.2 ( 6.9) -4.2 ( 6.8) Values are expressed as mean (SD); SBP=systolic blood pressure. DBP = diastolic blood pressure. HR = heart rate. Table 4 Syncope questionnaire by migraine subtype N Syncope ever Frequent Syncope Orthostatic Intolerance POTS OH Migraine overall 323 46% 13% 32% 3% 16% Migraine w/ Aura 174 43% 11% 32% 3% 14% Migraine w/out Aura 149 50% 15% 32% 4% 17% 1 Migraine attack 156 44% 14% 37% 3% 6% per month < 1 Migraine attack per month 167 49% 12% 28% 4% 15% Cardiovascular measurements The BP and HR measurements supine, while standing and after venipuncture did not differ significantly within both groups (Table 3). There was no significant difference in the prevalence of POTS and OH between the groups. Neither migraine type nor attack frequency ( 1 vs. < 1 attack per month) was associated with the presence of syncope, orthostatic intolerance, OH or POTS (Table 4). No correlation was found between the total number of migraine attacks and syncopal spells within the migraineurs. 138

Syncope in migraine Discussion In this population-based study, we examined clinical presentations of ANS dysfunction as well as BP and HR reflex tests in migraine. The lifetime prevalence of syncope we found in controls is in accordance with previous studies in air force personnel and medical students. 52,80 The population-based Framingham study of adults aged 30 to 62 years reported a lower lifetime prevalence of syncope (3.0% for men, 3.5% for women). 210 However, it seems plausible that these data referred to the incidence of syncope during the 26 year period of surveillance. 21 Moreover, syncope was not strictly defined in the Framingham study, resulting in inclusion of epilepsy, and even stroke or TIA as forms of syncope. 246 This may explain why risk factors for syncope identified in the Framingham Study lacked significance in our study. Given the high prevalence of vasovagal syncope, triggers for this type of syncope are more likely to affect estimates of the prevalence of syncope. 28,52 We found a higher lifetime prevalence of syncope and frequent syncope among migraineurs. The reported symptoms of migraineurs during prolonged standing, a warm shower, exercise, in the absence of complaints at venipuncture or after a heavy meal are best interpreted as orthostatic intolerance. 28,128 It is unclear why migraineurs have an increased tendency towards syncope and orthostatic intolerance. Our cardiovascular measurements underline that there is no gross abnormality of the ANS in migraine. However, we cannot exclude a slight sympathetic dysfunction as our study lacked a continuous blood pressure monitoring upon standing and therefore did not address the initial orthostatic response. Arguments favoring a slight sympathetic dysfunction in migraineurs, are the reduced plasma noradrenaline levels and alpha-adrenergic hypersensitivity. 194 Alternatively, syncope and orthostatic intolerance may occur as paroxysmal abnormalities without clear interictal signs of ANS dysfunction; if so, this parallels migraine itself, also characterized by largely normal interictal functions. Acknowledgements and Funding This study was supported by a grant from the Netherlands Heart Foundation (grant 97.108) and in part by the Intramural Research Program, NIA. The GEM study was conducted by the National Institute of Public Health and the Environment, department of Chronic Disease and Environmental Epidemiology, Bilthoven, the Netherlands. 139

140